IL7 and urinary bladder carcinoma: In contrast, IL7 has been reported to promote the proliferation and survival of tumor cells by activating the JAK/STAT, PI3K/AKT and RAS/ERK signaling pathways in non-small cell lung cancer, bladder cancer and T-cell acute lymphoblastic leukemia [15,42,43].